every patient is unique, their cancer treatment should be too
Kallisio creates personalized precision solutions for oncology.
Stentra™ — our first FDA cleared and CE marked device — is available now.
one size does
not fit all
when treatment isn’t built for the individual, patients pay the price
Generic, one-size-fits-all medical devices can’t account for each patient’s individual anatomy. The result: less precise treatment, avoidable side effects, and outcomes that fall short of what’s possible.
In head and neck cancer radiation therapy, for example, the consequences are well documented: painful mouth sores (mucositis), difficulty swallowing, treatment interruptions.
precision care built around the individual, not the average patient
At Kallisio, every solution we develop starts with the same principle – that effective treatment means accounting for each patient’s unique anatomy, not defaulting to one-size-fits-all. We’re building a pipeline of patient-specific solutions across oncology, each designed to reduce avoidable harm and improve outcomes.
Stentra™ is our first solution, and it’s already changing outcomes in head and neck radiation therapy.
Flagship product
Stentra™ custom 3D-printed immobilization device for a sub-millimeter precision fit
easily integrate precision into your treatment workflow
Capture your patient data
Step 1
1
Receive your patient-specific solution
Step 2
2
Treat your patient
Step 3
3
scalable innovation, one
patient at a time
gain up to 2–3 hours* per patient in workflow efficiency
The Stentra™ System improves efficiency by reducing simulation setup time and speeding up treatment planning. A patient-precision fit ensures easy reproducibility, minimizing delays and increasing accuracy.
*calculated from several clinical studies we can share
stentra™ is our first solution, it won't be our last
Kallisio is developing a pipeline of patient-specific oncology solutions each built on the same principle of precision personalized care. If you’re a clinician, partner, or investor interested in what’s coming next, we’d like to hear from you.
ready to bring precision care to your patients?
Join the cancer centres already using Stentra™ — Kallisio’s first FDA and CE cleared solution for head and neck radiation therapy. Our team will respond within 24 hours.
